Skin cancer immunotherapy offers less visible cure
Medical Republic,
26 September 2022 Disfiguring surgery on the head and neck could be avoided with neoadjuvant cemiplimab.
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Readers on
- mendeley
- 94 Mendeley